An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.

NCT00228059 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
132
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis